pharmaphorum July 8, 2020
External pressures and rapid scientific advancements are changing oncology forever, and innovative trials are needed to keep pace. Experts Andreas Dreps and Martin Lachs from ICON give us their thoughts on the future of cancer research and tell us how the CRO is staying adaptive.
There is arguably no disease area more dynamic than oncology. Over the past few years, scientific advancements have fundamentally changed (and continue to change) how doctors view and treat cancer. It wasn’t too long ago, for example, that immuno-oncology drugs...